Medicare Enrolled

Dr. Stanley Michalski, M.D.

Rheumatology · Williamsville, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
400 INTERNATIONAL DR., Williamsville, NY 14221
7166313555
In practice since 2005 (21 years)
NPI: 1386649721 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Michalski from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Michalski? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Michalski

Dr. Stanley Michalski is a rheumatology specialist in Williamsville, NY, with 21 years of NPI registration. Based on federal Medicare data, Dr. Michalski performed 281 Medicare services across 136 unique beneficiaries.

Between the years covered by Open Payments, Dr. Michalski received a total of $11,308 from 61 pharmaceutical and/or device companies across 711 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Michalski is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 21 years in practice ▲ 281 Medicare services $11,308 industry payments

Medicare Practice Summary

Medicare Utilization ↗
281
Medicare services
Bottom 29% in NY for rheumatology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
136
Unique beneficiaries
$49
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~13 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
147 $60 $213
Methylprednisolone acetate injection, 20 mg
A 20 mg injection of methylprednisolone acetate, a corticosteroid medication. This code specifies the drug and dosage administered.
66 $4 $18
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
43 $80 $314
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
25 $51 $203
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$11,308
Total received (2018-2024)
Avg $1,615/year across 7 years
Top 26% in NY for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
61
Companies
711
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,254 (99.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$54 (0.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,527
2023
$1,867
2022
$1,401
2021
$1,979
2020
$1,049
2019
$1,880
2018
$1,605

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$439
ABBVIE INC.
$258
Lilly USA, LLC
$143
Boehringer Ingelheim Pharmaceuticals, Inc.
$118
PFIZER INC.
$111
GlaxoSmithKline, LLC.
$106
BioCryst US Sales Co., LLC
$102
AstraZeneca Pharmaceuticals LP
$44
Exact Sciences Corporation
$44
Aurinia Pharma U.S., Inc.
$38
Janssen Biotech, Inc.
$22
Phathom Pharmaceuticals, Inc.
$20
E.R. Squibb & Sons, L.L.C.
$18
Regeneron Healthcare Solutions, Inc.
$17
Novo Nordisk Inc
$16
Genentech USA, Inc.
$16
SOBI, INC
$15
Top 3 companies account for 55.0% of 2024 payments
All-time payments by company (2018-2024) ›
PFIZER INC.
$1,463
Amgen Inc.
$1,183
Lilly USA, LLC
$916
ABBVIE INC.
$830
GlaxoSmithKline, LLC.
$754
Genentech USA, Inc.
$687
Abbott Laboratories
$656
E.R. Squibb & Sons, L.L.C.
$521
Boehringer Ingelheim Pharmaceuticals, Inc.
$419
Novartis Pharmaceuticals Corporation
$407
Takeda Pharmaceuticals U.S.A., Inc.
$334
Janssen Biotech, Inc.
$264
UCB, Inc.
$249
AstraZeneca Pharmaceuticals LP
$247
Novo Nordisk Inc
$185
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$184
Kowa Pharmaceuticals America, Inc.
$179
Amarin Pharma Inc.
$138
Janssen Pharmaceuticals, Inc
$137
Horizon Therapeutics plc
$127
BioCryst US Sales Co., LLC
$119
AbbVie Inc.
$106
Celgene Corporation
$92
Merck Sharp & Dohme Corporation
$71
Horizon Pharma plc
$66
Exact Sciences Corporation
$57
Aurinia Pharma U.S., Inc.
$56
Collegium Pharmaceutical, Inc.
$52
AbbVie, Inc.
$41
Phathom Pharmaceuticals, Inc.
$39
Merck Sharp & Dohme LLC
$38
GRT US Holding, Inc.
$36
Endo Pharmaceuticals Inc.
$36
Radius Health, Inc.
$35
Blueprint Medicines Corporation
$34
Vanda Pharmaceuticals Inc.
$34
Daiichi Sankyo Inc.
$33
Grifols USA, LLC
$32
GENZYME CORPORATION
$31
CSL Behring
$30
Medtronic, Inc.
$29
Orexo US, Inc.
$29
Supernus Pharmaceuticals, Inc.
$28
Sobi, Inc
$25
Octapharma USA, Inc.
$25
Ultragenyx Pharmaceutical Inc.
$22
Biogen, Inc.
$21
Astellas Pharma US Inc
$20
Gilead Sciences, Inc.
$18
Regeneron Healthcare Solutions, Inc.
$17
Mallinckrodt Hospital Products Inc.
$17
Alexion Pharmaceuticals, Inc.
$16
Celltrion USA Inc.
$16
SOBI, INC
$15
ARBOR PHARMACEUTICALS, INC.
$15
Mylan Specialty L.P.
$15
Allergan Inc.
$14
Scilex Pharmaceuticals Inc.
$14
SANOFI-AVENTIS U.S. LLC
$12
Arbor Pharmaceuticals, Inc.
$11
Mallinckrodt LLC
$10
Top 3 companies account for 31.5% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · Actemra · Amitiza · BASAGLAR · BELSOMRA · BENLYSTA · CHANTIX · COLOGUARD DNA CAPTURE REAGENTS · COSENTYX · CUVITRU · CYLTEZO · Cimzia · Cologuard Collection Kit · DUPIXENT · Dojolvi · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · Edarbi · Enbrel · FARXIGA · Gamunex-C · HETLIOZ · HUMIRA · Hizentra · Humira · ILARIS · INFINITY · INFLECTRA · INJECTAFER · INVOKANA · IONICRF · IonicRF Generator · JARDIANCE · KINERET · KRYSTEXXA · Kineret · LUPKYNIS · LYRICA · Livalo · MOUNJARO · MYRBETRIQ · Motegrity · NASCOBAL · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OCTRODE · OFEV · ORENCIA · ORLADEYO · Otezla · Ozempic · PREMARIN · Proclaim DRG IPG · Proclaim IPG · Proclaim XR IPG · Prolia · QULIPTA · Qutenza · RAYOS · REMICADE · RINVOQ · Repatha · Rituxan · Rybelsus · SAPHNELO · SEGLENTIS · SHINGRIX · SIMPONI ARIA · SKYRIZI · SOLIQUA 100/33 · SPIRIVA RESPIMAT · SPRAVATO · STELARA · STIOLTO RESPIMAT · STRENSIQ · SYMBICORT · TALTZ · TAVNEOS · TRADJENTA · TRELEGY ELLIPTA · TREMFYA · TRINTELLIX · TROKENDI XR · TRULICITY · TYSABRI · Trintellix · Tymlos · UBRELVY · VIBERZI · VOQUEZNA · VRAYLAR · Vascepa · XARELTO · XELJANZ · XIFAXAN · XTAMPZA · XTAMPZAER · YUFLYMA · Yupelri · ZEVO · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zubsolv
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a rheumatology specialist in Williamsville?
Compare rheumatologists in the Williamsville area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists within 10 mi
21
Per 100K population
2.2
County median income
$71,175
Nearest hospital
UPSTATE NEW YORK VA HEALTHCARE SYSTEM (WESTERN NY VA HEALTHCARE SYSTEM)
5.6 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Michalski is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 21 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Michalski experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Michalski performed 147 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Michalski receive payments from pharmaceutical companies?
Yes. Dr. Michalski received a total of $11,308 from 61 companies across 711 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Michalski's costs compare to other rheumatologists in Williamsville?
Dr. Michalski's average Medicare payment per service is $49. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Michalski) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →